![]() α-Avoparcin (R=H) β-Avoparcin (R=Cl) | |
Identifiers | |
---|---|
| |
3D model (JSmol) |
|
ChEMBL |
|
ChemSpider | |
ECHA InfoCard | 100.048.588 |
E number | E715 (antibiotics) |
KEGG |
|
PubChem CID | |
UNII |
|
| |
| |
Properties | |
C89H102ClN9O36 (α) C89H101Cl2N9O36 (β) | |
Molar mass | 1909.254 (α) 1943.699 (β) |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Avoparcin is a glycopeptide antibiotic effective against Gram-positive bacteria. It has been used in agriculture as an additive to livestock feed to promote growth in chickens, pigs, and cattle. [1] It is also used as an aid in the prevention of necrotic enteritis in poultry. [1]
Avoparcin is a mixture of two closely related chemical compounds, known as α-avoparcin and β-avoparcin, which differ by the presence of an additional chlorine atom in β-avoparcin. Avoparcin also shares a chemical similarity with vancomycin. Because of this similarity, concern exists that widespread use of avoparcin in animals may lead to an increased prevalence of vancomycin-resistant strains of bacteria. [2] [3] [4] [5]
Avoparcin was once widely used in Australia and the European Union, but it is currently not permitted in either. [1] [6]
Streptomyces candidus was found to produce avoparcin. [7]
Avoparcin is prohibited in the European Union, [8] Australia, and the United States. It was first banned in Denmark in 1995 as a feed additive, for its contributions to vancomycin-resistant Enterococcus (VRE), and later banned in several other European countries. [9] It was never approved for use in the United States. [10]